Lapatinib ditosylate anhydrous is a potent inhibitor of EGFR and ErbB2.
Lapatinib ditosylate anhydrous, an ErB-1 and ErB-2 dual kinase inhibitor, was launched for the treatment of advanced or metastatic HER2 (ErbB2) positive breast cancer in women who have received prior therapy.
|Product name||Lapatinib ditosylate anhydrous|
|Appearance||Yellow crystalline powder|
|Appearance:||Yellow crystalline powder|
|Package details:||1kg/foil bag; 25kg/drum|
Fortunachem Provides Not Only Professional Chemical Products But Also Professional Help
Keeping you up-to-date with all the latest information, news, and events about Fortunachem!